Xemperia

Switzerland
Grono, Grisons, Switzerland, 1723

Company profile

Xemperia company profile

At XEMPERIA, we are pioneering a groundbreaking concept for a blood test that effectively detects breast cancer at its earliest stage by harnessing the body’s immune response. Suitable for any women and age this innovative test offers superior performance to mammography and will serve as the first-line option in the breast cancer screening process.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2023-12-01, Month

Headquarters

Postal code
1723
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
1
Last funding
Debt Financing / $111,472 / 2024-06-26
Investors
1
Lead investors
1
Founders
3
Articles
5

Founders and investors

Founders

Curzio RueggSarah CattinTuto Rossi

Lead investors

Foundation for Innovation and Technology (FIT)

Investors

Foundation for Innovation and Technology (FIT)